Juvenescence Ltd 4
4 · AgeX Therapeutics, Inc. · Filed Mar 22, 2023
Insider Transaction Report
Form 4
Juvenescence Ltd
10% Owner
Transactions
- Gift
Common Stock
2023-03-14−16,447,500→ 0 total
Holdings
- 16,447,500(indirect: By Juvenescence US Corp.)
Common Stock
Footnotes (1)
- [F1]This transaction involved a transfer of securities to the reporting person's wholly owned subsidiary, Juvenescence US Corp.